Torthaí cuardaigh - Anusha Kalbasi

Beachtaigh na torthaí
  1. 1
    Tumour-intrinsic resistance to immune checkpoint blockade

    Tumour-intrinsic resistance to immune checkpoint blockade de réir Anusha Kalbasi, Antoni Ribas

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Radiation and immunotherapy: a synergistic combination

    Radiation and immunotherapy: a synergistic combination de réir Anusha Kalbasi, Carl H. June, Naomi B. Haas, Neha Vapiwala

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles.

    Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles. de réir Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach

    Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach de réir Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high‐risk pathologic features

    Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high‐risk pathologic features de réir Anusha Kalbasi, Samuel Swisher‐McClure, Nandita Mitra, R. Sunderland, Marc C. Smaldone, Robert G. Uzzo, Justin E. Bekelman

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma

    Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma de réir Anusha Kalbasi, Chad A. Komar, Graham M. Tooker, Mingen Liu, Jae W. Lee, Whitney L. Gladney, Edgar Ben‐Josef, Gregory L. Beatty

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer

    Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer de réir Anusha Kalbasi, Jiaqi Li, Abigail T. Berman, Samuel Swisher‐McClure, Marc C. Smaldone, Robert G. Uzzo, Dylan S. Small, Nandita Mitra, Justin E. Bekelman

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Antitumor Immune Responses in <i>B2M</i>-Deficient Cancers

    Antitumor Immune Responses in <i>B2M</i>-Deficient Cancers de réir Davis Y. Torrejon, Mildred Galvez, Gabriel Abril-Rodríguez, Katie M. Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comı́n-Anduix, Antoni Ribas

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

    SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study de réir Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal Barve, Gregory A. Daniels, Deborah Jean Lee Wong, Emmett V. Schmidt, Albert F. Candia, Robert L. Coffman, Abraham C.F. Leung, Robert Janssen

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

    A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases de réir Chong Xie, Grace Hyun J. Kim, Jonathan G Haw, Anusha Kalbasi, Brian Gardner, Gang Li, Jianyu Rao, David Chia, Monty Liong, Rubio Punzalan, Leonard S. Marks, Allan J. Pantuck, Alexandre de la Taille, Guomin Wang, Hideki Mukouyama, Gang Zeng

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma

    A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma de réir Anusha Kalbasi, Mitchell Kamrava, Fang‐I Chu, Donatello Telesca, Ritchell van Dams, Yingli Yang, Dan Ruan, Scott D. Nelson, Sarah Dry, Jackie Hernandez, Bartosz Chmielowski, Arun S. Singh, Susan V. Bukata, Nicholas M. Bernthal, Michael L. Steinberg, Joanne B. Weidhaas, Fritz C. Eilber

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs

    Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs de réir Yu Gao, Anusha Kalbasi, William Hsu, Dan Ruan, Jie Fu, Jiaxin Shao, Minsong Cao, Chenyang Wang, Fritz C. Eilber, Nicholas M. Bernthal, Susan V. Bukata, Sarah Dry, Scott D. Nelson, Mitchell Kamrava, John H. Lewis, Daniel A. Low, Michael L. Steinberg, Peng Hu, Yingli Yang

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

    Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma de réir Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Sarah Kremer, Katie M. Campbell, Juan M. Funes, Agustin Vega-Crespo, Giulia Parisi, Ameya Champekar, Christine Nguyen, Davis Y. Torrejon, Daniel Sanghoon Shin, Jesse M. Zaretsky, Robert Damoiseaux, Daniel E. Speiser, Pedro P. López‐Casas, Marisol Quintero, Antoni Ribas

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas

    Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas de réir J.D.D. Pennington, Fritz C. Eilber, Frederick R. Eilber, Arun S. Singh, Jarred P. Reed, Bartosz Chmielowski, Jeffrey J. Eċkardt, Susan V. Bukata, Nicholas M. Bernthal, Noah Federman, Scott D. Nelson, Sarah Dry, Pin‐Chieh Wang, Michael Luu, Michael T. Selch, Michael L. Steinberg, Anusha Kalbasi, Mitchell Kamrava

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

    A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab de réir Theodore S. Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, Rong Huang, Xiaoyan Wang, Jennifer Tsoi, Paula Kaplan‐Lefko, Paula Cabrera, Justin Tran, Jia Pang, Mignonette H. Macabali, Ivan Perez Garcilazo, Ignacio Baselga-Carretero, Anusha Kalbasi, Alistair J. Cochran, Catherine S. Grasso, Siwen Hu‐Lieskovan, Bartosz Chmielowski, Begoña Comı́n-Anduix, Arun D. Singh, Antoni Ribas

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    PAK4 inhibition improves PD-1 blockade immunotherapy

    PAK4 inhibition improves PD-1 blockade immunotherapy de réir Gabriel Abril-Rodríguez, Davis Y. Torrejon, Wei Liu, Jesse M. Zaretsky, Theodore S. Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J. Quist, Alejandro J. Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoña Comı́n-Anduix, Siwen Hu‐Lieskovan, Cun‐Yu Wang, Catherine S. Grasso, Antoni Ribas

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade

    Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade de réir Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar, Jennifer Tsoi, Katie M. Campbell, Anusha Kalbasi, Giulia Parisi, Jesse M. Zaretsky, Ángel García-Díaz, Cristina Puig-Saus, Gardenia Cheung-Lau, Thomas Wohlwender, Paige Krystofinski, Agustin Vega-Crespo, Christopher M. Lee, Pau Mascaro, Catherine S. Grasso, Beata Berent-Maoz, Begoña Comı́n-Anduix, Siwen Hu‐Lieskovan, Antoni Ribas

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Potentiating adoptive cell therapy using synthetic IL-9 receptors

    Potentiating adoptive cell therapy using synthetic IL-9 receptors de réir Anusha Kalbasi, Mikko Siurala, Leon Su, Mito Tariveranmoshabad, Lora K. Picton, Pranali Ravikumar, Peng Li, Jian‐Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah Kremer, Amy Sun, Sofia Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C. Rommel, Enrico Radaelli, Regina M. Young, Warren J. Leonard, Antoni Ribas, Carl H. June, K. Christopher García

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

    Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations de réir Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas, Ángel García-Díaz, Siwen Hu‐Lieskovan, Anusha Kalbasi, Catherine S. Grasso, Willy Hugo, Salemiz Sandoval, Davis Y. Torrejon, Nicolaos Palaskas, Gabriel Abril Rodriguez, Giulia Parisi, Ariel M. Azhdam, Bartosz Chmielowski, Grace Cherry, Elizabeth Seja, Beata Berent-Maoz, I. Peter Shintaku, Dung T. Le, Drew M. Pardoll, Luis A. Díaz, Paul C. Tumeh, Thomas G. Graeber, Roger S. Lo, Begoña Comı́n-Anduix, Antoni Ribas

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The landscape of drug sensitivity and resistance in sarcoma

    The landscape of drug sensitivity and resistance in sarcoma de réir Ahmad Al Shihabi, Peyton Tebon, Huyen Thi Lam Nguyen, Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y Jensen, Miranda Diaz-Infante, Hannah C. Cox, Alfredo Enrique Gonzalez, Summer Norris, Jantzen Sperry, Jonathan Nakashima, Nasrin Tavanaie, Helena Winata, Sorel Fitz‐Gibbon, Takafumi N. Yamaguchi, Jae Hoon Jeong, Sarah Dry, Arun S. Singh, Bartosz Chmielowski, Joseph G. Crompton, Anusha Kalbasi, Fritz C. Eilber, Francis J. Hornicek, Nicholas M. Bernthal, Scott D. Nelson, Paul C. Boutros, Noah Federman, Jane Yanagawa, Alice Soragni

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: